Angeles Wealth Management’s AstraZeneca AZN Stock Holding History

Angeles Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$429K	Buy	2,176 +1,006	+86%	+$194K	0.02%	259
2025 Q4	$215K	Buy	+1,170	New	+$205K	0.01%	348
2024 Q1	–	Sell	-1,530	Closed	-$206K	–	297
2023 Q4	$206K	Sell	1,530 -64	-4%	-$8.32K	0.03%	192
2023 Q3	$216K	Buy	+1,594	New	+$218K	0.03%	161

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Angeles Wealth Management's AZN Position: Q1 2026 in Review

Angeles Wealth Management increased its AstraZeneca (AZN) stake by 86% in Q1 2026, buying an estimated $194K and bringing the position to 2,176 shares worth $429K. The position accounts for 0.02% of the portfolio, ranked #259.

Angeles Wealth Management first reported a position in AZN in Q3 2023 and has held it in 4 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Angeles Wealth Management held 2,176 shares of AstraZeneca worth $429K as of Q1 2026.
Angeles Wealth Management bought 1,006 AstraZeneca shares in Q1 2026, an estimated $194K.
AstraZeneca made up 0.02% of Angeles Wealth Management's portfolio in Q1 2026, its #259 holding.
Angeles Wealth Management first reported a position in AstraZeneca in Q3 2023 and has held it in 4 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.